Form 4 Filing for Henderson John T at Cytokinetics Inc.

This filing details a transaction by Henderson John T, a director at Cytokinetics Inc. On July 15, 2026, 272 shares of common stock were acquired under the Cytokinetics Equity in lieu of Cash Retainer Program. These shares are fully vested at the time of grant. The transaction code was 'A', indicating acquisition. The price per share was $82.62, and the post-transaction shares owned by Henderson John T amount to 78,360. Additionally, the filing notes that 83 shares of common stock are held indirectly and are owned by a spouse.